RTTNews | Feb 9, 2021 07:29AM EST

07:29 Tuesday, February 9, 2021 (RTTNews.com) - Incyte Corp. (INCY) on Tuesday reported a net income of $149.85 million or $0.68 per share for the fourth quarter, up from $111.01 million or $0.51 per share in the prior-year quarter.

Excluding items, adjusted net income for the quarter was $0.93 per share, compared to $0.65 per share in the year-ago quarter.

Total revenues for the quarter rose to $789.51 million from $579.39 million in the same quarter last year.

On average, analysts polled by Thomson Reuters expected the company to report earnings of $0.75 per share on revenues of $662.94 million for the quarter. Analysts' estimates typically exclude special items.

Looking ahead to fiscal 2021, Incyte now projects Jakafi net product revenue in a range of $2.125 billion to $2.20 billion. Other Hematology/Oncology net product revenues are projected between $145 million and $160 million.

Read the original article on RTTNews ( https://www.rttnews.com/3168144/incyte-q4-results-top-estimates-quick-facts.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved